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Bone area provides a responsive outcome measure for bone changes in short-term knee 
osteoarthritis studies Michael A Bowes1, Rose A Maciewicz2, John C Waterton3, David J Hunter4, 
Philip G Conaghan
5 
Abstract 
Objective: This post-hoc study analyzed 3D bone area from an osteoarthritis (OA) cohort 
demonstrating no change in cartilage thickness. 
Methods: 27 women with painful medial knee OA had MRI at 0, 3 and 6 months. Images were 
analysed using active appearance models. 
Results:At 3 and 6 months the mean change in medial femoral bone area was 0.34% [95% CI 0.04, 
0.64] and 0.61% [CI 0.32, 0.90].  40% of subjects had progression > SDD at 6 months. 
Conclusion:  In this small cohort at high risk of OA progression, bone area changed at 3 and 6 months 
when cartilage morphometric measures did not.    
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Introduction 
There is an urgent need for treatments to arrest structural progression in osteoarthritis (OA).  
However, we lack responsive measures (biomarkers) which could be used in early phase evaluation 
of investigational therapies.  Radiography and magnetic resonance imaging (MRI) offer many 
structural biomarkers, but currently these require larger sample sizes and longer duration of 
treatment than would be ideal in a Phase 2 study.  
Bone is integral to the OA pathological process and a number of bony pathologies including 
subchondral bone thickening, trabecular morphometry, bone marrow lesions and bone shape have 
been investigated (1). There is likely to be considerable interplay between the subchondral bone and 
cartilage (2). Changes in bone shape and area have been shown to be predictive biomarkers for the 
onset of knee osteoarthritis (3, 4), and  can be accurately quantified using active appearance 
modelling (AAM), a form of statistical shape modelling that enables automatic segmentation.(Figure 
1) (5, 6).  Recent studies in large cohorts have shown that change in 3D bone area is specific for knee 
OA and more responsive than radiographic joint space width and cartilage thickness (7).   
A previous study designed to assess the responsiveness of cartilage thickness in a small knee OA 
cohort enriched for known risk factors of progression including high BMI, female gender and varus 
alignment demonstrated no significant change in cartilage thickness at the group level in the medial 
femur or tibia at 3 or 6 months (8). The current post-hoc study analysed the changes in bone area of 
the femoral condyles in this cohort to determine the responsiveness of this novel bone biomarker. 
Materials and Methods 
29 participants were recruited in a multi-centre, non-randomized, observational cohort study at four 
sites in the USA (8).  27 females had knee pain, a body mass index (BMI) ≥ 25 kg/m
2
, radiographic 
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evidence of medial OA,varus malalignment, and images at all timepoints, 2 did not have all images.   
A single knee was selected, being the knee with highest KL score, or the right knee if no difference. 
MR images were acquired using 3T Siemens systems, using the dual echo steady state water 
excitation acquisition sequence (DESS-we), previously used in the Osteoarthritis Initiative (9).  MR 
images were acquired at recruitment, with follow-up images at 1 week (providing a double baseline), 
3 and 6 months.  Ethics approval was obtained from the sites involved in the study and all 
participants gave informed consent.  
Images were automatically segmented using AAMs of the femur, built using an unrelated training set 
(7), which has been shown to segment with point-to-surface accuracy of less than 1mm (10).  Two 
area measures (mm
2
) were extracted from the bone surface produced by the AAM: the medial and 
lateral femorotibial regions of the femur (Figure 1), which were found to be the most responsive 
regions in a larger study (7). 
Repeat baseline MRI scans were acquired a week apart (8), allowing estimation of repeatability by 
calculation of root-mean-square coefficients of variation (CoV), and smallest detectable difference 
(SDD),  defined as the mean of the differences ±1.96 standard deviations. Change over time was 
assessed using a paired t-test of the ratio of the value of each timepoint against the baseline value, 
using the geometric mean of the 2 baseline images.  Spatial location of bone area change was 
visualised by colour change maps, and displayed on the mean bone shape (Figure 2). 
Results 
The mean age was 62 years (range 50 - 80).  Mean BMI at baseline was 35 kg/m
2
 (31 - 44); mean 
WOMAC pain score was 7 (1-12).  Mean knee alignment was 0.4° (-1.9° to +6.3°) (varus positive); 12 
of 27 were left knees.  19 knees were Kellgren Lawrence Grade 3; the remainder were Grade 2.   
Repeatability for the MF region was 0.39% (CoV) and 1.1% (SDD), and for the LF region was 0.66% 
(CoV), 1.9% (SDD). At 3 months the mean change in MF bone area was 0.34% [95% confidence 
Page 4 of 19
For Peer Review
interval (CI) (0.04, 0.64), p=0.03] and at 6 months 0.61% [CI 0.32, 0.90, p=0.0002]; baseline MF area 
= 2291 mm
2
.  In the LF region, the changes were not significant at 3 months 0.24% [CI -0.17%, 0.66, 
p=0.23], but became significant at 6 months 0.49% [CI 0.18, 0.80, p=0.0021] (Figure 1); baseline = 
1527 mm
2
.  Standardised Response Mean (SRM) of MF at 3:6 months were 0.45:0.85 and for LF at 6 
months was 0.66.  There were no significant differences between the KL 2 and KL3 groups, for 
example, MF region changed 0.32 (-0.01,0.65) at 3 months, and 0.57 (0.25,0.89) in the KL3 group, 
and 0.34(-0.18,0.50) at 3 months, 0.63(0.5,0.76) at 6 months in the KL2 group (all values in percent). 
Previously reported (3) cartilage thickness change was not significant at any time point, and showed 
no trend with time.  Mean change at 3 months for medial femoral cartilage was -1.3% [range -2.9, 
0.3], at 6 months 0.8% [range -1.4, 3.0]; baseline = 1.54 mm.  Mean change at 3 months for medial 
tibial cartilage was 1.3% [range -3.9, 1.7], at 6 months -1.0% [range -3.2, 1.2]; baseline = 2.27 mm.   
Graphs of change with time for each participant are shown in Figure 3, together with the SDD for 
each measure.  Bone area measures showed increasing numbers of progressors (those with change 
greater than the SDD) with time, but progressors outnumbered regressors at each point.   41% of 
subjects progressed more than SDD using the MF bone area measure at 6 months (11 subjects), 
compared with 15% who lost cartilage greater than SDD in the MT region (4 subjects).  
The spatial pattern of change was similar to that reported in a larger study (7).  Increase in area was 
seen in articulating tibiofemoral surfaces, together with a circumferential increase in bone area 
around the cartilage plate, in the osteophytic region (Figure 2). 
Discussion 
In this small, short-term study of people with OA knee selected for high risk of structural 
progression, 3D bone area using AAMs demonstrated change in 3 months for the medial femoral 
region, and for both femoral regions at 6 months. Previous analysis of this dataset did not 
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demonstrate significant change in cartilage thickness (1), one of the most promising MRI biomarkers 
of OA progression to date (11). 
Though the participant numbers were small in this study, the change shows a clear trend in bone 
area change, with 3-month change about half that at 6 months. Rates of area change per bone 
region were also similar to those reported from a large OA longitudinal dataset, which showed 
annual change of 0.75% in the MF region, as compared to 1.2% in this study (3), further supporting 
the validity of these findings.  
The structural endpoints in most clinical trials in the musculoskeletal area, such as those for 
rheumatoid arthritis where good treatments and patient responses are common, are driven by a few 
percent of progressors (change greater than SDD) because of the relationship between small 
changes and large measurement noise  This study is notable, both because significant change is 
detected in the population, but also because the change shows a clear trend with time, and is 
greater than SDD in a significant number of participants.   
Power calculations, using an SRM of 0.85, the value for change in MF region at 6 months, assuming 
intervention had 50% reduction, one-sided, 80% power, L=0.05%, show that cohorts of ~80 persons 
would be needed for each arm of an intervention study. 
Longitudinal change in bone area has been reported elsewhere (12, 13).  These studies have 
primarily considered tibial rather than femoral bone, and use 2D methods of identification of area.  
The repeatability of AAMs resulted in an SDD of approximately 1% compared to 4% in these previous 
studies.  
There are limitations to this work. It is reasonable to expect that there may be some relationship 
between changes in bone and cartilage, but no relationship was seen in this admittedly small study.  
While this analysis was based on an appropriately collected, well designed study, it does represent a 
post-hoc analysis. The MRI scanners and imaging sequences employed in this study were as used in 
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the Osteoarthritis Initiative (9).  The images derived from these MRI scans were not optimised to 
visualise bone, so further responsiveness may be possible with dedicated bone sequences. We have 
only provided data on one 3D bone shape biomarker (bone area) and other measures, such as those 
that measure other regions within the subchondral bone, may be more responsive.  
This study compared bone area with one specific method of cartilage measurement; other methods, 
and other variables such as volume may provide better responsiveness. However, we are not aware 
of any method showing significant cartilage change in less than 30 people in 6 months.   
In this small cohort selected for high risk of OA progression, bone area changed in an approximately 
linear manner at 3 and 6 months from baseline.  Bone area shows promise as a highly sensitive 
biomarker of OA progression, detecting change when current imaging outcomes are unable to do so, 
and provides a potential tool for small, short-duration, proof of concept studies, such as those with a 
treatment likely to affect bone.  
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Bone area provides a responsive outcome measure for bone changes in short-term knee 
osteoarthritis studies Bone area provides a responsive outcome measure in short-term knee 
osteoarthritis studies Michael A Bowes1, Rose A Maciewicz2, John C Waterton3, David J Hunter4, 
Philip G Conaghan
5 
Abstract 
Objective: This post-hoc study analyzed 3D bone area from an osteoarthritis (OA) cohort 
demonstrating no change in cartilage thickness. 
Methods: 27 women with painful medial knee OA had MRI at 0, 3 and 6 months. Images were 
analysed using active appearance models. 
Results:At 3 and 6 months the mean change in medial femoral bone area was 0.34% [95% CI 0.04, 
0.64] and 0.61% [CI 0.32, 0.90].  40% of subjects had progression > SDD at 6 months. 
Conclusion:  In this small cohort at high risk of OA progression, bone area changed at 3 and 6 months 
when cartilage morphometric measures did not.    
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Introduction 
There is an urgent need for treatments to arrest structural progression in osteoarthritis (OA).  
However, we lack responsive measures (biomarkers) which could be used in the early phase 
evaluation of investigational therapies.  Radiography and magnetic resonance imaging (MRI) offer 
many structural biomarkers of structural change, but currently these require larger sample sizes and 
longer duration of treatment than would be ideal in a Phase 2 study of an investigational therapy.  
Bone is integral to the OA pathological process and a number of bony pathologies including 
subchondral bone thickening, trabecular morphometry, bone marrow lesions and bone shape have 
been investigated (1). There is likely to be considerable interplay between the subchondral bone and 
cartilage (2). Changes in bone shape and area have been shown to be predictive biomarkers for the 
onset of knee osteoarthritis (3, 4), and  can be accurately quantified using active appearance 
modelling (AAM), a form of statistical shape modelling that enables automatic segmentation.(Figure 
1) (5, 6).  Recent studies in large cohorts have shown that change in 3D bone area is specific for knee 
OA and more responsive than radiographic joint space width and cartilage thickness (7).   
A previous study designed to assess the responsiveness of cartilage thickness in a small knee OA 
cohort enriched for known risk factors of progression including high BMI, female gender and varus 
alignment demonstrated no significant change in cartilage thickness at the group level in the medial 
femur or tibia at 3 or 6 months (8). The current post-hoc study analysed the changes in bone area of 
the femoral condyles in this cohort to determine the responsiveness of this novel bone biomarker. 
Materials and Methods 
29 participants were recruited in a multi-centre, non-randomized, observational cohort study at four 
sites in the USA (8).  27 females had knee pain, a body mass index (BMI) ≥ 25 kg/m
2
, radiographic 
evidence of medial OA, and varus malalignment, and images at all timepoints, 2 did not have all 
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images.   A single knee was selected, being the knee with the highest KL score, or the right knee if no 
difference. 
MR images were acquired using 3T Siemens systems, using the dual echo steady state water 
excitation acquisition sequence (DESS-we), as previously used in the Osteoarthritis Initiative (9).  MR 
images were acquired at recruitment, with follow-up images at 1 week (providing a double baseline), 
3 months and 6 months.  Ethics approval was obtained from the sites involved in the study and all 
participants gave informed consent.  
Images were automatically segmented using AAMs of the femur, built using an unrelated training set 
(7), which has been shown to segment with point-to-surface accuracy of less than 1mm (10).  Two 
area measures (mm
2
) were extracted from the triangulated bone surface produced by the AAM: the 
medial and lateral femorotibial regions of the femur (Figure 1), which were found to be the most 
responsive regions in a larger study (7). 
In the original imaging of participants,R repeat baseline MRI scans were acquired a week apart (8), 
allowing estimation of repeatability by calculation of root-mean-square coefficients of variation 
(CoV), and smallest detectable difference (SDD),  defined as the mean of the differences ±1.96 
standard deviations. Change over time was assessed using a paired t-test of the ratio of the value of 
each timepoint against the baseline value, using either the geometric mean of the 2 baseline images.  
The sSpatial location of bone area change was visualised by colour change maps, and displayed on 
the mean bone shape (Figure 2). 
Results 
The mean age was 62 years (range 50 - 80).  Mean BMI at baseline was 35 kg/m
2
 (range 31 - 44); 
mean WOMAC pain score was 7 (range 1-12).  Mean knee alignment was 0.4° (range -1.9° to +6.3°) 
(varus positive);, and 12 of 27 were left knees.  19 knees were Kellgren Lawrence Grade 3; the 
remainder were Grade 2.   
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Repeatability for the MF region was 0.39% (CoV) and 1.1% (SDD), and for the LF region was 0.66% 
(CoV), and 1.9% (SDD). At 3 months the mean change in MF bone area was 0.34% [95% confidence 
interval (CI) (0.04, 0.64), p=0.03] and at 6 months 0.61% [CI 0.32, 0.90, p=0.0002]; baseline MF area 
= 2291 mm
2
.  In the LF region, the changes were not significant at 3 months 0.24% [CI -0.17%, 0.66, 
p=0.23], but became significant at 6 months 0.49% [CI 0.18, 0.80, p=0.0021] (Figure 1) ; baseline = 
1527 mm
2
.  Standardised Response Mean (SRM) of MF at 3:6 months were 0.45:0.85 and for LF at 6 
months was 0.66.  There were no significant differences between the KL 2 and KL3 groups, for 
example, MF region changed 0.32 (-0.01,0.65) at 3 months, and 0.57 (0.25,0.89) in the KL3 group, 
and 0.34(-0.18,0.50) at 3 months, 0.63(0.5,0.76) at 6 months in the KL2 group (all values in 
percent).No significant differences were seen between KL2 and 3 knees (data not shown). 
Previously reported (3) cartilage thickness change was not significant at any time point, and showed 
no trend with time.  Mean change at 3 months for medial femoral cartilage was -1.3% [range -2.9, 
0.3], at 6 months 0.8% [range -1.4, 3.0]; baseline = 1.54 mm.  Mean change at 3 months for medial 
tibial cartilage was 1.3% [range -3.9, 1.7], at 6 months -1.0% [range -3.2, 1.2]; baseline = 2.27 mm.   
Graphs of change with time for each participant are shown in Figure 3, together with the SDD for 
each measure.  Bone area measures showed increasing numbers of progressors (those with change 
greater than the SDD) with time, but progressors outnumbered regressors at each point.   41% of 
subjects progressed more than SDD using the MF bone area measure at 6 months (11 subjects), 
compared with 15% who lost cartilage greater than SDD in the MT region (4 subjects).  
The spatial pattern of change was similar to that reported in a larger study (7).  Increase in area was 
seen in articulating tibiofemoral surfaces, together with a circumferential increase in bone area 
around the cartilage plate, in the osteophytic region (Figure 2). 
Discussion 
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In this small, short-term study of people with OA knee selected for high risk of structural 
progression, 3D bone area using AAMs demonstrated change in 3 months for the medial femoral 
region, and for both femoral regions at 6 months. Previous analysis of this dataset did not 
demonstrate significant change in cartilage thickness (1), one of the most promising MRI biomarkers 
of OA progression to date (11). 
Though the participant numbers were small in this study, the change shows a clear trend in bone 
area change, with the 3-month change about half that at 6 months. Rates of area change per bone 
region were also similar to those reported from a large OA longitudinal dataset, which showed 
annual change of 0.75% in the MF region, as compared to 1.2% in this study (3), further supporting 
the validity of these findings.  
The structural endpoints in most clinical trials in the musculoskeletal area, such as those for 
rheumatoid arthritis where good treatments and patient responses are common, are driven by a few 
percent of progressors (those change greater than SDD) because of the relationship between small 
changes and large measurement noise.  In such trials, it is uncommon for the mean change of the 
population to exceed the SDD.  This study is notable, both because significant change is detected in 
the population, but also because the change shows a clear trend with time, and is measurable 
greater than SDD in a significant number of participants.   
Power calculations, using an SRM of 0.85, the value for change in MF region at 6 months, assuming 
intervention had 50% reduction, one-sided, 80% power, L=0.05%, show that cohorts of ~80 persons 
would be needed for each arm of an intervention study. 
Longitudinal change in bone area has been reported elsewhere (12, 13).  These studies have 
primarily considered tibial rather than femoral bone, and use 2D methods of identification of area.  
The repeatability of AAMs resulted in an SDD of approximately 1% compared to 4% in these previous 
studies.  
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There are limitations to this work. It is reasonable to expect that there may be some relationship 
between changes in bone and cartilage, but no relationship was seen in this admittedly small study.  
While this analysis was based on an appropriately collected, well designed study, it does represent a 
post-hoc analysis. The MRI scanners and imaging sequences employed in this study were as used in 
the Osteoarthritis Initiative (9).  The images derived from these MRI scans were not optimised to 
visualise bone, so further responsiveness may be possible with dedicated bone sequences. We have 
only provided data on one 3D bone shape biomarker (bone area) and other measures, such as those 
that measure other specific sites of changeregions within the subchondral bone, may be more 
informativeresponsive.  
This study compared bone area with one specific method of cartilage measurement; other methods, 
and other variables such as volume may provide better responsiveness. However, we are not aware 
of any method showing significant cartilage change in less than 30 people in 6 months.   
In this small cohort selected for high risk of OA progression, bone area changed in an approximately 
linear manner at 3 and 6 months from baseline.  Bone area shows promise as a highly sensitive 
biomarker of OA progression, detecting change when current imaging outcomes are unable to do so, 
and provides a potential tool for small, short-duration, proof of concept studies, such as those with a 
treatment likely to affect bone.  
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